[1] TORREALDAY S, KODAMAN P, PAL L. Premature Ovarian Insufficiency - an update on recent advances in understanding and management. F1000Res. 2017;6:2069.
[2] 吴洁,陈蓉.早发性卵巢功能不全的激素补充治疗专家共识[J].中华妇产科杂志,2016,51(12):881-886.
[3] PITTENGER MF, MACKAY AM, BECK SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411): 143-147.
[4] JIANG Y, JAHAGIRDAR BN, REINHARDT RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002; 418(6893):41-49.
[5] KRAMPERA M, PASINI A, PIZZOLO G, et al. Regenerative and immunomodulatory potential of mesenchymal stem cells. Curr Opin Pharmacol. 2006;6(4):435-441.
[6] ULLAH I, SUBBARAO RB, RHO GJ. Human mesenchymal stem cells - current trends and future prospective. Biosci Rep. 2015;35(2):e00191.
[7] ZAHER W, HARKNESS L, JAFARI A, et al. An update of human mesenchymal stem cell biology and their clinical uses. Arch Toxicol. 2014;88(5):1069-1082.
[8] LI H, ZHAO W, WANG L, et al. Human placenta-derived mesenchymal stem cells inhibit apoptosis of granulosa cells induced by IRE1α pathway in autoimmune POF mice. Cell Biol Int. 2019;43(8):899-909.
[9] GABR H, RATEB MA, EL SISSY MH, et al. The effect of bone marrow-derived mesenchymal stem cells on chemotherapy induced ovarian failure in albino rats. Microsc Res Tech. 2016;79(10):938-947.
[10] LU X, CUI J, CUI L, et al. The effects of human umbilical cord-derived mesenchymal stem cell transplantation on endometrial receptivity are associated with Th1/Th2 balance change and uNK cell expression of uterine in autoimmune premature ovarian failure mice. Stem Cell Res Ther. 2019;10(1):214.
[11] YANG M, LIN L, SHA C, et al. Bone marrow mesenchymal stem cell-derived exosomal miR-144-5p improves rat ovarian function after chemotherapy-induced ovarian failure by targeting PTEN. Lab Invest. 2020;100(3):342-352.
[12] ELFAYOMY AK, ALMASRY SM, EL-TARHOUNY SA, et al. Human umbilical cord blood-mesenchymal stem cells transplantation renovates the ovarian surface epithelium in a rat model of premature ovarian failure: Possible direct and indirect effects. Tissue Cell. 2016;48(4):370-382.
[13] WANG Z, WANG Y, YANG T, et al. Study of the reparative effects of menstrual-derived stem cells on premature ovarian failure in mice. Stem Cell Res Ther. 2017;8(1):11.
[14] 王琰,杨瑛,刘兵,等.骨髓间充质干细胞移植对VCD所致卵巢损伤的修复研究[J].现代生物医学进展,2011,11(10):1844-1846,1850.
[15] 陈京京,殷慧群,汪存利,等.骨髓间充质干细胞移植在卵巢早衰小鼠卵巢及生育功能重建中的作用[J].安徽医科大学学报,2017, 52(11):1611-1615.
[16] 柳颖灵,刘炜,纪亚忠. SDF-1/CXCR4轴在间充质干细胞治疗卵巢早衰中的研究进展[J].实用临床医学,2015,16(7): 100-103,107.
[17] LIU T, LI Q, WANG S, et al. Transplantation of ovarian granulosa‑like cells derived from human induced pluripotent stem cells for the treatment of murine premature ovarian failure. Mol Med Rep. 2016;13(6): 5053-5058.
[18] LIU T, HUANG Y, ZHANG J, et al. Transplantation of human menstrual blood stem cells to treat premature ovarian failure in mouse model. Stem Cells Dev. 2014;23(13):1548-1557.
[19] 杜静,刘文慧,王婷,等.人脐带间充质干细胞对卵巢早衰大鼠卵巢超微结构和功能的影响[J].现代妇产科进展,2018,27(2):127-130.
[20] SONG D, ZHONG Y, QIAN C, et al. Human Umbilical Cord Mesenchymal Stem Cells Therapy in Cyclophosphamide-Induced Premature Ovarian Failure Rat Model. Biomed Res Int. 2016;2016:2517514.
[21] CHEN X, WANG Q, LI X, et al. Heat shock pretreatment of mesenchymal stem cells for inhibiting the apoptosis of ovarian granulosa cells enhanced the repair effect on chemotherapy-induced premature ovarian failure. Stem Cell Res Ther. 2018;9(1):240.
[22] FU X, HE Y, WANG X, et al. Overexpression of miR-21 in stem cells improves ovarian structure and function in rats with chemotherapy-induced ovarian damage by targeting PDCD4 and PTEN to inhibit granulosa cell apoptosis. Stem Cell Res Ther. 2017;8(1):187.
[23] ZHENG Q, FU X, JIANG J, et al. Umbilical Cord Mesenchymal Stem Cell Transplantation Prevents Chemotherapy-Induced Ovarian Failure via the NGF/TrkA Pathway in Rats. Biomed Res Int. 2019;2019:6539294.
[24] ZHANG M, METHOT D, POPPA V, et al. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol. 2001;33(5):907-921.
[25] 汪庆如,陈小莹,李欣然,等.过表达miR-21的骨髓间充质干细胞对化疗性卵巢早衰的修复作用[J].解放军医学杂志,2019,44(3): 203-209.
[26] LAI D, WANG F, YAO X, et al. Human endometrial mesenchymal stem cells restore ovarian function through improving the renewal of germline stem cells in a mouse model of premature ovarian failure. J Transl Med. 2015;13:155.
[27] MANSHADI MD, NAVID S, HOSHINO Y, et al. The effects of human menstrual blood stem cells-derived granulosa cells on ovarian follicle formation in a rat model of premature ovarian failure. Microsc Res Tech. 2019;82(6):635-642.
[28] NOORY P, NAVID S, ZANGANEH BM, et al. Human Menstrual Blood Stem Cell-Derived Granulosa Cells Participate in Ovarian Follicle Formation in a Rat Model of Premature Ovarian Failure In Vivo. Cell Reprogram. 2019;21(5):249-259.
[29] 李慧,陈曦,昌晓红.脐带间充质干细胞与卵巢早衰中颗粒细胞交互作用的研究进展[J].中国医药生物技术, 2019,14(3):263-265.
[30] FU X, HE Y, XIE C, et al. Bone marrow mesenchymal stem cell transplantation improves ovarian function and structure in rats with chemotherapy-induced ovarian damage. Cytotherapy. 2008;10(4): 353-363.
[31] YAO X, GUO Y, WANG Q, et al. The Paracrine Effect of Transplanted Human Amniotic Epithelial Cells on Ovarian Function Improvement in a Mouse Model of Chemotherapy-Induced Primary Ovarian Insufficiency. Stem Cells Int. 2016;2016:4148923.
[32] LI J, YU Q, HUANG H, et al. Human chorionic plate-derived mesenchymal stem cells transplantation restores ovarian function in a chemotherapy-induced mouse model of premature ovarian failure. Stem Cell Res Ther. 2018;9(1):81.
[33] CARRION B, KONG YP, KAIGLER D, et al. Bone marrow-derived mesenchymal stem cells enhance angiogenesis via their α6β1 integrin receptor. Exp Cell Res. 2013;319(19):2964-2976.
[34] HERRAIZ S, ROMEU M, BUIGUES A, et al. Autologous stem cell ovarian transplantation to increase reproductive potential in patients who are poor responders. Fertil Steril. 2018;110(3):496-505.
[35] YIN N, ZHAO W, LUO Q, et al. Restoring Ovarian Function With Human Placenta-Derived Mesenchymal Stem Cells in Autoimmune-Induced Premature Ovarian Failure Mice Mediated by Treg Cells and Associated Cytokines. Reprod Sci. 2018;25(7):1073-1082.
[36] YIN N, WANG Y, LU X, et al. hPMSC transplantation restoring ovarian function in premature ovarian failure mice is associated with change of Th17/Tc17 and Th17/Treg cell ratios through the PI3K/Akt signal pathway. Stem Cell Res Ther. 2018;9(1):37.
[37] LAI D, WANG F, DONG Z, et al. Skin-derived mesenchymal stem cells help restore function to ovaries in a premature ovarian failure mouse model. PLoS One. 2014;9(5):e98749.
[38] 宋开静,何援利,蔡慧华,等.异体脂肪间充质干细胞对卵巢早衰患者外周血调节性T细胞的影响[J].解放军医学杂志,2018,43(4): 294-298.
[39] WANG S, YU L, SUN M, et al. The therapeutic potential of umbilical cord mesenchymal stem cells in mice premature ovarian failure. Biomed Res Int. 2013;2013:690491.
[40] 彭静,肖娜,程腊梅.骨髓来源间充质干细胞对卵巢早衰小鼠的修复作用[J].中南大学学报(医学版),2018,43(1):7-13.
[41] HUŁAS-STASIAK M, GAWRON A. Follicular atresia in the prepubertal spiny mouse (Acomys cahirinus) ovary. Apoptosis. 2011;16(10):967-975.
[42] YIN N, WU C, QIU J, et al. Protective properties of heme oxygenase-1 expressed in umbilical cord mesenchymal stem cells help restore the ovarian function of premature ovarian failure mice through activating the JNK/Bcl-2 signal pathway-regulated autophagy and upregulating the circulating of CD8+CD28- T cells. Stem Cell Res Ther. 2020;11(1):49.
[43] LI B, HU X, YANG Y, et al. GAS5/miR-21 Axis as a Potential Target to Rescue ZCL-082-Induced Autophagy of Female Germline Stem Cells In Vitro. Mol Ther Nucleic Acids. 2019;17:436-447.
[44] LIU M, QIU Y, XUE Z, et al. Small extracellular vesicles derived from embryonic stem cells restore ovarian function of premature ovarian failure through PI3K/AKT signaling pathway. Stem Cell Res Ther. 2020; 11(1):3.
[45] NIE M, YU S, PENG S, et al. miR-23a and miR-27a promote human granulosa cell apoptosis by targeting SMAD5. Biol Reprod. 2015; 93(4):98.
[46] DING C, ZHU L, SHEN H, et al. Exosomal miRNA-17-5p derived from human umbilical cord mesenchymal stem cells improves ovarian function in premature ovarian insufficiency by regulating SIRT7. Stem Cells. 2020;38(9):1137-1148.
[47] DING C, QIAN C, HOU S, et al. Exosomal miRNA-320a Is Released from hAMSCs and Regulates SIRT4 to Prevent Reactive Oxygen Species Generation in POI. Mol Ther Nucleic Acids. 2020;21:37-50.
[48] JOHNSON J, CANNING J, KANEKO T, et al. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature. 2004; 428(6979):145-150.
[49] LIU J, SHANG D, XIAO Y, et al. Isolation and characterization of string-forming female germline stem cells from ovaries of neonatal mice. J Biol Chem. 2017;292(39):16003-16013.
[50] SILVESTRIS E, D’ORONZO S, CAFFORIO P, et al. In Vitro Generation of Oocytes from Ovarian Stem Cells (OSCs): In Search of Major Evidence. Int J Mol Sci. 2019;20(24):6225.
[51] YANG Y, LEI L, WANG S, et al. Transplantation of umbilical cord-derived mesenchymal stem cells on a collagen scaffold improves ovarian function in a premature ovarian failure model of mice. In Vitro Cell Dev Biol Anim. 2019;55(4):302-311.
[52] TAUCHMANOVÀ L, SELLERI C, DE ROSA G, et al. Estrogen-progestin therapy in women after stem cell transplant: our experience and literature review. Menopause. 2007;14(2):320-330.
[53] 李慧,张琛,崔恒,等.人脐带间充质干细胞治疗早发性卵巢功能不全的研究进展[J].中国妇产科临床杂志,2017,18(5): 478-480.
[54] DING C, LI H, WANG Y, et al. Different therapeutic effects of cells derived from human amniotic membrane on premature ovarian aging depend on distinct cellular biological characteristics. Stem Cell Res Ther. 2017;8(1):173.
[55] 叶小凤,何援利,付霞霏,等.骨髓间充质干细胞移植治疗顺铂致卵巢的化疗性损伤[J].中国组织工程研究,2015,19(10):1597-1602.
|